Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05417386
Title FOLFIRINOX + NIS793 in Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Colin D. Weekes, M.D.
Indications

pancreatic adenocarcinoma

pancreatic adenosquamous carcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + NIS793 + Oxaliplatin

Capecitabine + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST